Qiagen NV at JPMorgan Healthcare Conference (Virtual) Transcript
Okay. Good morning, I'm Tycho Peterson from the Life Science team. It's my pleasure to introduce our next company this morning, QIAGEN. Just a reminder for those that have questions to submit them through the website.
And with that, I'll turn it over to Thierry.
Thank you so much, Tycho, and good morning, good afternoon, and good evening to all of you. Happy New Year on behalf for QIAGEN. So my name is Thierry Bernard, and my agenda today is to show you that we believe that QIAGEN emerged from 2020 as an independent, stronger and more focused company for the coming years, ready to execute on significant growth post-pandemic.
Moving to Slide 3, let me remind you who we are in a nutshell. The 5,300 QIAGENers all over the world are developing for more than 20 years now, cutting-edge solutions in Molecular Biology, both for life science and clinical applications.
At the last officially
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
